Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092561796> ?p ?o ?g. }
- W3092561796 abstract "Abstract Background Identification of master regulators (MRs) using transcriptome data in cervical cancer (CC) could help us to develop biomarkers and find novel drug targets to fight this disease. Methods We performed differential expression (DE) analyses of public microarray and RNA-seq transcriptome data of CC and normal cervical tissues (N). Virtual Inference of Protein activity by Enriched Regulon analysis (VIPER) was used to convert the DE outcomes to differential activity (DA) signature for MRs. Synergy analysis was conducted to study synergistic effect of MR-pairs. TCGA and microarray data were used to test the association of expression of a MR and a clinical feature or a molecular feature (e.g. somatic mutations). Various bioinformatic tools/websites (DAVID, GEPIA2, Oncomine, cBioPortal) were used to analyze the expression of the top MRs and their regulons. Results Ten DE and 10 DA signatures were generated for CC. Two MRs, DNA topoisomerase II alpha ( TOP2A ) and centromere protein F ( CENPF ) were found to be up-regulated, activated and synergistic in CC compared to N across the 10 datasets. The two MRs activate a common set of genes (regulons) with functions in cell cycle, chromosome, DNA damage etc. Higher expression of CENPF was associated with metastasis. High expression of both MRs is associated with somatic mutation of a set of genes including tumor suppressors ( TP53 , MSH2 , RB1 ) and genes involved in cancer pathways, cell cycle, DNA damage and repair. The magnitude of up-regulation and the absolute expression level of both MRs in CC are significantly higher compared to many other cancer types. Conclusion TOP2A and CENPF are a synergistic pair of MRs that are overexpressed and activated in CC. Their high expression is correlated with some prognosis features (e.g. metastasis) and molecular features (e.g. somatic mutations) and distinctly high in CC vs. many other cancer types. They may be good biomarkers and anticancer drug targets for CC." @default.
- W3092561796 created "2020-10-15" @default.
- W3092561796 creator A5005642187 @default.
- W3092561796 creator A5006165634 @default.
- W3092561796 creator A5012324763 @default.
- W3092561796 creator A5015578891 @default.
- W3092561796 creator A5016281551 @default.
- W3092561796 creator A5023634611 @default.
- W3092561796 creator A5032927018 @default.
- W3092561796 creator A5037647145 @default.
- W3092561796 creator A5044367029 @default.
- W3092561796 creator A5050360222 @default.
- W3092561796 creator A5051162011 @default.
- W3092561796 creator A5052994834 @default.
- W3092561796 creator A5059969775 @default.
- W3092561796 creator A5077057193 @default.
- W3092561796 creator A5081183372 @default.
- W3092561796 creator A5082601498 @default.
- W3092561796 creator A5083505449 @default.
- W3092561796 creator A5086984057 @default.
- W3092561796 date "2020-10-06" @default.
- W3092561796 modified "2023-10-01" @default.
- W3092561796 title "TOP2A and CENPF are synergistic master regulators activated in cervical cancer" @default.
- W3092561796 cites W1169587918 @default.
- W3092561796 cites W1498643847 @default.
- W3092561796 cites W1875984885 @default.
- W3092561796 cites W1980939996 @default.
- W3092561796 cites W2013700000 @default.
- W3092561796 cites W2024010247 @default.
- W3092561796 cites W2026125672 @default.
- W3092561796 cites W2041109563 @default.
- W3092561796 cites W2046462883 @default.
- W3092561796 cites W2053449688 @default.
- W3092561796 cites W2068256179 @default.
- W3092561796 cites W2077128508 @default.
- W3092561796 cites W2082668371 @default.
- W3092561796 cites W2089006618 @default.
- W3092561796 cites W2105605394 @default.
- W3092561796 cites W2114843025 @default.
- W3092561796 cites W2116041602 @default.
- W3092561796 cites W2145865840 @default.
- W3092561796 cites W2148028028 @default.
- W3092561796 cites W2158217645 @default.
- W3092561796 cites W2159675211 @default.
- W3092561796 cites W2169456326 @default.
- W3092561796 cites W2179438025 @default.
- W3092561796 cites W2261971875 @default.
- W3092561796 cites W2329659234 @default.
- W3092561796 cites W2341128841 @default.
- W3092561796 cites W2342019990 @default.
- W3092561796 cites W2370300800 @default.
- W3092561796 cites W2382523398 @default.
- W3092561796 cites W2472255748 @default.
- W3092561796 cites W2574669282 @default.
- W3092561796 cites W2575837388 @default.
- W3092561796 cites W2612467560 @default.
- W3092561796 cites W2613629789 @default.
- W3092561796 cites W2767003118 @default.
- W3092561796 cites W2768077738 @default.
- W3092561796 cites W2771475233 @default.
- W3092561796 cites W2771510573 @default.
- W3092561796 cites W2790774242 @default.
- W3092561796 cites W2791808804 @default.
- W3092561796 cites W2807638806 @default.
- W3092561796 cites W2899545420 @default.
- W3092561796 cites W2900569176 @default.
- W3092561796 cites W2903836745 @default.
- W3092561796 cites W2938542170 @default.
- W3092561796 cites W2943953652 @default.
- W3092561796 cites W2944727022 @default.
- W3092561796 cites W2946657092 @default.
- W3092561796 cites W2974047793 @default.
- W3092561796 cites W2977724228 @default.
- W3092561796 cites W2979796834 @default.
- W3092561796 cites W4211097225 @default.
- W3092561796 doi "https://doi.org/10.1186/s12920-020-00800-2" @default.
- W3092561796 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7541258" @default.
- W3092561796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33023625" @default.
- W3092561796 hasPublicationYear "2020" @default.
- W3092561796 type Work @default.
- W3092561796 sameAs 3092561796 @default.
- W3092561796 citedByCount "17" @default.
- W3092561796 countsByYear W30925617962021 @default.
- W3092561796 countsByYear W30925617962022 @default.
- W3092561796 countsByYear W30925617962023 @default.
- W3092561796 crossrefType "journal-article" @default.
- W3092561796 hasAuthorship W3092561796A5005642187 @default.
- W3092561796 hasAuthorship W3092561796A5006165634 @default.
- W3092561796 hasAuthorship W3092561796A5012324763 @default.
- W3092561796 hasAuthorship W3092561796A5015578891 @default.
- W3092561796 hasAuthorship W3092561796A5016281551 @default.
- W3092561796 hasAuthorship W3092561796A5023634611 @default.
- W3092561796 hasAuthorship W3092561796A5032927018 @default.
- W3092561796 hasAuthorship W3092561796A5037647145 @default.
- W3092561796 hasAuthorship W3092561796A5044367029 @default.
- W3092561796 hasAuthorship W3092561796A5050360222 @default.
- W3092561796 hasAuthorship W3092561796A5051162011 @default.
- W3092561796 hasAuthorship W3092561796A5052994834 @default.
- W3092561796 hasAuthorship W3092561796A5059969775 @default.
- W3092561796 hasAuthorship W3092561796A5077057193 @default.